Stock events for Healthpeak Properties, Inc. (DOC)
Over the past six months, Healthpeak Properties stock has experienced a share price decline of 10.64% as of June 25, 2025, trading near 10-year and 52-week lows. The company successfully integrated the merger with Physicians Realty Trust, surpassing synergy targets. Healthpeak reported mixed earnings results for Q4 2024 and Q1 2025. The Board of Directors declared a 1.7% increase in the quarterly common stock cash dividend in February 2025 and transitioned to a monthly dividend in April 2025. In Q1 2025, Healthpeak repurchased 1.1 million shares for approximately $22 million. In February 2025, Healthpeak issued $500 million of 5.375% fixed-rate 10-year senior unsecured notes. Analysts have a consensus "Strong Buy" rating for Healthpeak Properties, with an average 12-month price target of $22.00.
Demand Seasonality affecting Healthpeak Properties, Inc.’s stock price
Demand for Healthpeak Properties' products and services is primarily driven by long-term demographic trends and advancements in healthcare, such as increasing life expectancy and growth in biopharma drug development. The rising senior citizen population and their higher healthcare expenditure benefit Healthpeak's continuing care retirement community portfolio, suggesting a relatively stable and growing demand influenced by demographic shifts rather than pronounced seasonal fluctuations.
Overview of Healthpeak Properties, Inc.’s business
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) primarily focused on healthcare-related facilities in the United States. The company operates within the Real Estate sector, specifically as a Healthcare Facility REIT. Healthpeak's portfolio is diversified across three main segments: Lab, Outpatient Medical, and Continuing Care Retirement Community (CCRC) properties. Its major products and services involve acquiring, developing, owning, leasing, and managing healthcare properties. Lab properties consist of laboratory and office spaces primarily leased to biotechnology, medical device, and pharmaceutical companies, as well as scientific research institutions and government agencies involved in the life science industry. Outpatient Medical properties include multi-tenant buildings primarily leased to healthcare providers, with a significant portion located on or adjacent to hospital campuses and affiliated with hospital systems. Continuing Care Retirement Communities (CCRCs) are retirement communities offering a continuum of care, including independent living, assisted living, memory care, and skilled nursing units. In March 2024, Healthpeak completed a strategic merger with Physicians Realty Trust, which significantly expanded its outpatient medical footprint.
DOC’s Geographic footprint
Healthpeak Properties, Inc. operates across the United States, with a portfolio of approximately 462 in-place properties located in 31 states. The company has a significant presence in key high-growth urban markets, particularly for its lab segment in San Francisco, San Diego, and Boston. Following the merger with Physicians Realty Trust, Healthpeak expanded its presence in New York and Cambridge, Massachusetts. The company is headquartered in Denver, Colorado, with additional corporate offices in California, Tennessee, Wisconsin, and Massachusetts, and property management offices throughout the U.S.
DOC Corporate Image Assessment
In the past year, Healthpeak Properties has received positive recognition for its sustainability and responsible business practices, including LEED Gold Core & Shell awards and being named to Newsweek's America's Greenest Companies list. The company released its 2023 Corporate Impact Report in June 2024, highlighting its commitment to environmental, social, and governance factors.
Ownership
Healthpeak Properties is primarily owned by institutional shareholders, who hold approximately 93.92% of the company's stock. Insiders own about 1.58%, and retail investors hold approximately 4.50%. Major institutional owners include Vanguard Group Inc, BlackRock, Inc., and State Street Corp.
Ask Our Expert AI Analyst
Price Chart
$17.51